Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost (Centre national de génotypage [fr]). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.

Epigenomics
DisciplineEpigenomics
LanguageEnglish
Edited byJames G. Herman, Jörg Tost
Publication details
History2009–present
Publisher
FrequencyMonthly
4.778 (2020)
Standard abbreviations
ISO 4Epigenomics
Indexing
CODENEPIGC7
ISSN1750-1911 (print)
1750-192X (web)
OCLC no.746948365
Links

Abstracting and indexing

edit

The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2017 impact factor of 4.979, ranking it 31st out of 166 journals in the category "Genetics & Heredity".[1]

References

edit
  1. ^ "Journals Ranked by Impact: Genetics & Heredity". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
edit